Misplaced Pages

Juan Pedro Bolaños

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Spanish researcher
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
This article contains promotional content. Please help improve it by removing promotional language and inappropriate external links, and by adding encyclopedic text written from a neutral point of view. (May 2023) (Learn how and when to remove this message)
This biographical article is written like a résumé. Please help improve it by revising it to be neutral and encyclopedic. (May 2023)
(Learn how and when to remove this message)
Juan Pedro Bolaños
BornJuan Pedro Bolaños Hernández
(1964-04-18) April 18, 1964 (age 60)
Santa María de Guía de Gran Canaria, Las Palmas
NationalitySpanish
EducationUniversity of Salamanca
Occupation(s)Professor of Biochemistry and Molecular Biology Neuroscience Researcher
EmployerUniversity of Salamanca
AwardsMarie Curie Excellence Award

Premio Castilla y León de Investigación Científica y Técnica e Innovación

Bachelard Lectureship Award

Juan Pedro Bolaños Hernández (born April 18, 1964, Santa María de Guía de Gran Canaria, Las Palmas) is a biochemist and neuroscientist specializing in neuroenergetics and metabolism. He is a professor of Biochemistry and Molecular Biology at the University of Salamanca. His investigation focuses on the understanding of molecular mechanisms that regulate the metabolism and redox homeostasis in the cells of the central nervous system. He has received several recognitions throughout his scientific career. Among them is the Premio Castilla y León de Investigación Científica y Técnica e Innovación (Award Castilla y León for Scientific and Technical Research and Innovation).

Professional career

He comes from a family of pharmacists. During his childhood, he helped his father with some tasks in his laboratory of clinical analyses in his local town. It was here where he began being interested in chemistry, applied to biology, and eventually to the pharmaceutical sciences.

He studied Pharmaceutical Sciences at the University of Salamanca, where he graduated with honors in 1987. Later he obtained a doctorate at the same university under the tutelage of Dr. José Mª Medina Jiménez. During his PhD, he did a research internship in Oxford, England, where he worked in the Metabolic Research Laboratory under the supervision of Dereck Williamson. In 1992 he defended his PhD thesis on the metabolism of valproic acid in the central nervous system, graduating with honors that same year. After his PhD he worked as a postdoctoral fellow from 1993 to 1995 at the Institute of Neurology of the University College of London as a Marie Curie scholar.

In 1996 he became a professor in the Department of Biochemistry and Molecular Biology at the University of Salamanca. A year later, in 1997 he established his own research group and started working on a project funded by the Ministry of Science and Technology. From 1997 to 2004 he acted as Academic Secretary in the Department of Biochemistry and Molecular Biology. He completed the national professorship habilitation test in 2005, and in 2007 he was incorporated as a full professor at the University of Salamanca.

His research group is located at the Institute of Functional and Genomic Biology, a mixed center University of Salamanca, and the Spanish National Research Council. It is recognized as a Group of Excellence of Castilla y León. The group has research collaborations with research centers at national and international levels, among which the University Hospital of Salamanca, University College London, and the Institute of Health Saint Carlos III.

He has been an editor in multiple international scientific journals such as Science, PNAS, Nature Communications, Nature Reviews Neuroscience, and Cell Metabolism. In 2021, the journal Neurochemical Research dedicated a special issue with articles related to his research lines to honor his academic career. Furthermore, he is part of reviewing boards at international organizations such as the Human Frontier Program Organization, FWO, Wellcome Trust, Parkinson's UK, Michael J. Fox Foundation, among others.

He has participated in committees of organization and direction of different research conferences and scientific events. In 2017 together with Gilles Bonvento, they organized a symposium on redox and metabolic interactions between neurons and astrocytes. In 2022 together with Giovanni Mariscano and Anne-Karine Bouzier-Sore directed the course Bioenergetics for Brain Functions as part of the Cajal Advanced Neuroscience Training Programme. During that same year, he directed the summer school of the International Society of Neurochemistry and the Journal of Neurochemistry under the theme of Cerebral Metabolism in Health and Disease.

Research

His research focuses on understanding the molecular mechanisms that regulate the metabolism and redox homeostasis in the cells of the central nervous system. In particular, the study of the proteins and signaling pathways responsible for the adaptation of the neural metabolism at high energy demands and antioxidants imposed by neurotransmission. Among the research aims of his teamwork, besides the advancement of knowledge, is to identify metabolic targets and genetic alterations that contribute to the malfunctioning of neurotransmission that neurological problems, including neurodegenerative diseases, and even contribute to aging. To attain it, they have a research project consisting of the validation of the protein phosphatase 2c(pp2c) in psychotic states and to tackle the disorder by consumption of cannabis. Furthermore, they evaluate the pharmacological potential of neuroprotective compounds in the treatment of Parkinson's disease and Alzheimer's disease. Another of his research lines consists of the metabolic rescheduling of the astrocytes and their impact on neural function.

Awards and recognitions

His educational work, research, and academic pathway, have been recognized and awarded in multiple occasions by national and international organizations.

  • 2005: Marie Curie Excellence Award. Awarded by the European Commission in recognition of his research work.
  • 2008 to 2011: Recognition as editor of the year of the scientific journal Biochemical Journal.
  • 2019: Prize María de Maeztu of scientific excellence. Awarded by the University of Salamanca.
  • 2021: A homage by the scientific magazine Neurochemical Research standing out his academic and scientific career.
  • 2021: Premio Castilla y León de Investigación Científica y Técnica e Innovación. In recognition of his scientific publications, international collaborations, and his projection of a future as an ambassador of science in Castilla y León.
  • 2022: Bachelard Lectureship Award. Awarded by the European Society for Neurochemistry for the lecture entitled Metabolic shapes of brain cells and functional consequences.

Scientific societies

He belongs to several scientific societies, and even in some of them has been part of the board of directors.

Scientific production

Throughout his career in academia, he has supervised multiple national and international students and directed their doctoral theses, some of them have received European distinction. He has published more than 150 scientific articles in high-impact academic journals. Due to his number of citations he has been appointed as one of the most notable scientists in the world in the list elaborated by Stanford University.

Among his scientific publications stood out the following:

  • PINK1 deficiency sustains cell proliferation by reprogramming glucose metabolism through HIF1. Exposing that the deficiency of the protein PINK1, involved in Parkinson's disease, affects the survival of the neurons.
  • Astrocytic mitochondrial ROS modulate brain metabolism and mouse behavior. Which shows that reactive oxygen species produced by the astrocytes have a protective effect on the neurons.
  • Aberrant upregulation of the glycolytic enzyme PFKFB3 in CLN7 Neural ceroid lipofuscinosis. Explaining the mechanism of degradation of the neurons in Batten disease and proposes a pharmacological strategy to avoid it.
  • Glucose metabolism links astroglial mitochondria to cannabinoid effects. Exposing the relationship between the energetic metabolism of the brain, the consumption of cannabis, and the lack of social interaction.
  • Targeting PFKFB3 alleviates Cerebral ischemia-reperfusion injury in mice. Exposing a potential treatment to prevent neural death, which can be used in cases of traumatic brain injury, brain ischemia, amyotrophic lateral sclerosis, Alzheimer's disease, or Huntington's disease.

According to Scopus, his most cited scientific publications are:

  • The bioenergetic and antioxidant Status of neurons is controlled by continuous degradation of to key glycolytic enzyme by APC/C–Cdh1.
  • Nitric oxide‐mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases.
  • Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture.
  • Nitric oxide, cell bioenergetics and neurodegeneration.
  • Nitric oxide, mitochondria and neurological disease.

References

  1. University of Salamanca. "Juan Pedro Bolaños Hernández". produccioncientifica.usal.es. p. Portal de la Investigación. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  2. G, L (April 5, 2022). "Juan Pedro Bolaños, catedrático de la Universidad de Salamanca, Premio Castilla y León de Investigación". La Gaceta de Salamanca (in Spanish). Salamanca, Spain. pp. Salamanca. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  3. ^ "Neuroenergetics and Metabolism Group". Instituto de Biología Funcional y Genómica. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  4. RDL (April 21, 2022). "Juan Pedro Bolaños, premio Castilla y León de investigación: "Es urgente que España suba la financiación para investigar"". La Gaceta de Salamanca. pp. Salamanca. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  5. ^ Moreno, Amado (April 16, 2022). ""El Estado está lejos de llegar al menos al 2% de PIB para la investigación"". El Periódico de España (in Spanish). pp. Investigación. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  6. ^ "Juan P Bolaños". loop.frontiers. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  7. Junta de Castilla y León, Portal de Educación (2009). "Catálogo Programas I+D+I Grupos de Excelencia" (PDF) (in Spanish). p. Servicio de Investigación Científica. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  8. Universidad de Salamanca. "Juan Pedro Bolaños Hernández: Colaboradores". usal.es (in Spanish). p. Portal de Investigación. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  9. ^ Baas, Jeroen; Boyack, Kevin; Ioannidis, John P. A. (October 19, 2021). "August 2021 data-update for "Updated science-wide author databases of standardized citation indicators"". Elsevier Data Repository. 3. Elsevier BV. doi:10.17632/btchxktzyw.3. Archived from the original on February 21, 2022. Retrieved April 7, 2023.
  10. ^ "Nuevo reconocimiento para el investigador Juan Pedro Bolaños". El Norte de Castilla (in Spanish). Salamanca, Spain. February 5, 2021. pp. Noticias Salamanca. Archived from the original on August 13, 2023. Retrieved April 7, 2023.
  11. International Society of Neurochemistry (2017). "Report of ISN Supported Small Conference" (PDF). Archived (PDF) from the original on May 18, 2023. Retrieved April 7, 2023.
  12. Cajal Advanced Neuroscience Training (2021). "Bioenergetics for Brain Function". Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  13. International Society of Neuroscience (2021). "4th ISN-JNC Flagship School: "Brain Metabolism in Health and Disease"". Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  14. Universidad de Salamanca. "Juan Pedro Bolaños Hernández: Proyectos". p. Portal de Investigación. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  15. ^ "Investigador de la USAL avanza en identificación de nuevos mecanismos neurodegenerativos en la enfermedad de Batten". Europa Press. Salamanca, Spain. January 27, 2022. pp. Castilla y León. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  16. "Dos científicos españoles reciben el premio de investigación Marie Curie". El Mundo. Spain. December 12, 2005. pp. Actualidad. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  17. AVPR (December 2, 2005). "El salmantino Juan Pedro Bolaños, premio europeo de investigación Marie Curie Excellence 2005". Agencia de Noticias para la difusión de la Ciencia y la Tecnología. Salamanca, Spain. Agencia Iberoamericana para la Difusión de la Ciencia y la Tecnología. pp. Ciencia España. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  18. Monroy, Silvia (December 7, 2005). "El premio 'Marie Curie' en Neurobiología es canario". Canarias. Canary Islands, Spain. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  19. Biochemical Journal. "Editorial Board". Portland Press. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  20. "Homenaje al PDI". Universidad de Salamanda. Salamanca, Spain. 2019. pp. Protocolo. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  21. "La revista científica 'Neurochemical Research' dedica un número especial al investigador de la Universidad de Salamanca Juan Pedro Bolaños". Salamanca 24 horas. Salamanca, Spain. February 4, 2021. pp. Universidad. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  22. "Juan Pedro Bolaños extiende el Premio CyL de Investigación al personal de su laboratorio de la Universidad". El Norte de Castilla. Salamanca, Spain. April 5, 2022. pp. Noticias Salamanca. Archived from the original on August 13, 2023. Retrieved April 7, 2023.
  23. "El catedrático de Bioquímica y Biología Molecular Juan Pedro Bolaños Hernández, Premio CyL de Investigación". Europa Press. Valladolid, Spain. April 5, 2022. pp. Castilla y León. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  24. León (April 5, 2022). "Juan Pedro Bolaños Hernández, Premio Castilla y León de Investigación Científica y Técnica e Innovación". Leonoticias. pp. Castilla y León. Archived from the original on August 13, 2023. Retrieved April 7, 2023.
  25. European Society for Neuochemistry (2022). "The European Society for Neurochemistry congratulates 2022 Young Scientist Lectureship Awardees and Young Member Symposium Winners" (PDF). European Society for Neuochemistry. Archived (PDF) from the original on April 7, 2023. Retrieved April 7, 2023.
  26. Boullerne, Anne I.; Foley, Paul; Turner, Anthony J.; Johnston, Graham A.R.; Beart, Philip M. (July 29, 2019). "The origins and early history of neurochemistry and its societies". Journal of Neurochemistry. 152 (1): 8–28. doi:10.1111/jnc.14839. hdl:11343/286491. ISSN 0022-3042. PMID 31357242. S2CID 198982752.
  27. International Society of Neurochemistry. "Committees: ISN-JNC Flagship School". neurochemistry.org. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  28. Sociedad Española de Bioquímica y Biología Molecular. "Cónsules SEBBM". sebbm.es (in Spanish). Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  29. Universidad de Salamanca. "Juan Pedro Bolaños Hernández: Tesis". usal.es. p. Portal de Investigación. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  30. "Juan Pedro Bolaños recoge el Premio Castilla y León de Investigación Científica y Técnica e Innovación". Agencia Iberoamericana para la Difusión de Ciencia y Tecnología. Castile and Leon, Spain. April 22, 2022. pp. Salud España. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  31. Requejo-Aguilar, Raquel; Lopez-Fabuel, Irene; Fernandez, Emilio; Martins, Luis M.; Almeida, Angeles; Bolaños, Juan P. (2014-07-24). "PINK1 deficiency sustains cell proliferation by reprogramming glucose metabolism through HIF1". Nature Communications. 5 (1): 4514. Bibcode:2014NatCo...5.4514R. doi:10.1038/ncomms5514. ISSN 2041-1723. PMID 25058378. S2CID 7870574.
  32. Pichel Andrés, José (July 24, 2014). "Determinada la importancia de una proteína para el desarrollo del párkinson". Agencia Iberoamericana para la Difusión de la Ciencia y la Tecnología (in Spanish). Salamanca, Spain. pp. Salud España. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  33. Vicente-Gutierrez, Carlos; Bonora, Nicoló; Bobo-Jimenez, Veronica; Jimenez-Blasco, Daniel; Lopez-Fabuel, Irene; Fernandez, Emilio; Josephine, Charlene; Bonvento, Gilles; Enriquez, Jose A.; Almeida, Angeles; Bolaños, Juan P. (February 4, 2019). "Astrocytic mitochondrial ROS modulate brain metabolism and mouse behaviour". Nature Metabolism. 1 (2): 201–211. doi:10.1038/s42255-018-0031-6. ISSN 2522-5812. PMID 32694785. S2CID 257113112. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  34. Pichel Andrés, José (February 4, 2019). "Las especies reactivas de oxígeno producidas por los astrocitos ejercen un efecto protector sobre las neuronas". Agencia Iberoamericana para la Difusión de la Ciencia y la Tecnología. pp. Salud España. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  35. Lopez-Fabuel, Irene; Garcia-Macia, Marina; Buondelmonte, Costantina; Burmistrova, Olga; Bonora, Nicolo; Alonso-Batan, Paula; Morant-Ferrando, Brenda; Vicente-Gutierrez, Carlos; Jimenez-Blasco, Daniel; Quintana-Cabrera, Ruben; Fernandez, Emilio; Llop, Jordi; Ramos-Cabrer, Pedro; Sharaireh, Aseel; Guevara-Ferrer, Marta (2022-01-27). "Aberrant upregulation of the glycolytic enzyme PFKFB3 in CLN7 neuronal ceroid lipofuscinosis". Nature Communications. 13 (1): 536. Bibcode:2022NatCo..13..536L. doi:10.1038/s41467-022-28191-1. ISSN 2041-1723. PMC 8795187. PMID 35087090.
  36. "Científicos de Salamanca logran avances contra la enfermedad de Batten". Agencia Iberoamericana para la Difusión de la Ciencia y la Tecnología (in Spanish). Salamanca, Spain. January 27, 2022. pp. Salud España. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  37. "Científicos salmantinos le plantan cara a la enfermedad de Batten". La Crónica de Salamanca (in Spanish). Salamanca, Spain. January 27, 2022. pp. Local. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  38. NCYL (January 27, 2022). "La USAL identifica nuevos mecanismos en la neurodegeneración en la enfermedad rara de Batten". El Español. Salamanca, Spain. pp. Investigación. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  39. Jimenez-Blasco, Daniel; Busquets-Garcia, Arnau; Hebert-Chatelain, Etienne; Serrat, Roman; Vicente-Gutierrez, Carlos; Ioannidou, Christina; Gómez-Sotres, Paula; Lopez-Fabuel, Irene; Resch-Beusher, Monica; Resel, Eva; Arnouil, Dorian; Saraswat, Dave; Varilh, Marjorie; Cannich, Astrid; Julio-Kalajzic, Francisca (July 8, 2020). "Glucose metabolism links astroglial mitochondria to cannabinoid effects". Nature. 583 (7817): 603–608. Bibcode:2020Natur.583..603J. doi:10.1038/s41586-020-2470-y. ISSN 1476-4687. PMID 32641832. S2CID 256819755. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  40. "Se rompe un mito: El cannabis no ayuda a socializarse". La Crónica de Salamanca (in Spanish). Salamanca, Spain. July 8, 2020. pp. Local. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  41. Burmistrova, Olga; Olias-Arjona, Ana; Lapresa, Rebeca; Jimenez-Blasco, Daniel; Eremeeva, Tatiana; Shishov, Dmitry; Romanov, Sergei; Zakurdaeva, Kristina; Almeida, Angeles; Fedichev, Peter O.; Bolaños, Juan P. (2019-08-12). "Targeting PFKFB3 alleviates cerebral ischemia-reperfusion injury in mice". Scientific Reports. 9 (1): 11670. Bibcode:2019NatSR...911670B. doi:10.1038/s41598-019-48196-z. ISSN 2045-2322. PMC 6691133. PMID 31406177. S2CID 92795340.
  42. "Investigadores salmantinos encuentran un medicamento para prevenir los ictus". La Crónica de Salamanca. Salamanca, Spain. August 14, 2019. pp. Local. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  43. "Bolaños, Juan Pedro". Elsevier. Archived from the original on August 13, 2023. Retrieved April 7, 2023.
  44. Herrero-Mendez, Angel; Almeida, Angeles; Fernández, Emilio; Maestre, Carolina; Moncada, Salvador; Bolaños, Juan P. (May 17, 2009). "The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C–Cdh1". Nature Cell Biology. 11 (6): 747–752. doi:10.1038/ncb1881. ISSN 1476-4679. PMID 19448625. S2CID 19519317. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  45. Bolaños, Juan P.; Almeida, Angeles; Stewart, Victoria; Peuchen, Stephan; Land, John M.; Clark, John B.; Heales, Simon J. R. (2002-11-18). "Nitric Oxide-Mediated Mitochondrial Damage in the Brain: Mechanisms and Implications for Neurodegenerative Diseases". Journal of Neurochemistry. 68 (6): 2227–2240. doi:10.1046/j.1471-4159.1997.68062227.x. PMID 9166714. S2CID 8838691.
  46. Bolaños, Juan P.; Heales, Simon J. R.; Land, John M.; Clark, John B. (2002-11-23). "Effect of Peroxynitrite on the Mitochondrial Respiratory Chain: Differential Susceptibility of Neurones and Astrocytes in Primary Culture". Journal of Neurochemistry. 64 (5): 1965–1972. doi:10.1046/j.1471-4159.1995.64051965.x. PMID 7722484. S2CID 20928061. Archived from the original on 2023-08-13. Retrieved 2023-04-07.
  47. Moncada, Salvador; Bolanos, Juan P. (June 19, 2006). "Nitric oxide, cell bioenergetics and neurodegeneration". Journal of Neurochemistry. 97 (6): 1676–1689. doi:10.1111/j.1471-4159.2006.03988.x. ISSN 0022-3042. PMID 16805776. S2CID 32062718. Archived from the original on April 7, 2023. Retrieved April 7, 2023.
  48. Heales, Simon J. R.; Bolaños, Juan P.; Stewart, Victoria C.; Brookes, Paul S.; Land, John M.; Clark, John B. (1999-02-09). "Nitric oxide, mitochondria and neurological disease". Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1410 (2): 215–228. doi:10.1016/S0005-2728(98)00168-6. ISSN 0005-2728. PMID 10076028. Archived from the original on 2023-04-07. Retrieved 2023-04-07.
Categories: